Assessing and Implementing Artificial Intelligence in Radiology
In a recent video interview, Nina Kottler, MD, discussed the promise of artificial intelligence (AI) for improving workflow efficiency for radiologists, keys to assessing AI vendors and change management principles for facilitating implementation of AI into one’s practice.
There is fair amount of excitement and hype about the ongoing emergence of artificial intelligence (AI) and the potential promise of the technology in improving diagnostic accuracy and increasing workflow efficiencies in radiology.
However, as Nina Kottler, MD, points out in a recent video interview with Diagnostic Imaging, there are challenges as well when it comes to assessment and implementation of AI into one’s practice. While there are “hundreds of FDA-cleared and approved algorithms in radiology alone,” she notes that it is “early on in the maturity of the technology of AI with respect to health care” so choosing the right AI vendor for your practice is critical.
While technical prowess is important, 80 percent of what an AI vendor does is help create the workflow around the algorithm to ensure it works well, according to Dr. Kottler, the Associate Chief Medical Officer for Clinical AI and VP of Clinical Operations at Radiology Partners. Dr. Kottler says cultural alignment is an important consideration as you are seeking a vendor that values your input as a radiologist and is on a similar wavelength with you on future directions of AI in radiology.
For pertinent insights on the assessment and implementation of AI technology, watch the video below.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
